HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 6,000 Shares

HilleVax, Inc. (NASDAQ:HLVXGet Free Report) Director Aditya Kohli sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $14.73, for a total value of $88,380.00. Following the sale, the director now owns 764,878 shares of the company’s stock, valued at $11,266,652.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Aditya Kohli also recently made the following trade(s):

  • On Monday, May 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.45, for a total value of $92,700.00.
  • On Friday, May 3rd, Aditya Kohli sold 723 shares of HilleVax stock. The shares were sold at an average price of $14.15, for a total value of $10,230.45.
  • On Wednesday, May 1st, Aditya Kohli sold 175 shares of HilleVax stock. The stock was sold at an average price of $14.03, for a total transaction of $2,455.25.
  • On Friday, April 5th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $14.44, for a total transaction of $86,640.00.
  • On Wednesday, April 3rd, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $14.93, for a total transaction of $89,580.00.
  • On Wednesday, March 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $164,221.00, for a total value of $985,326,000.00.
  • On Monday, March 18th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $17.66, for a total value of $105,960.00.
  • On Friday, March 8th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $18.66, for a total value of $111,960.00.
  • On Wednesday, March 6th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $18.95, for a total value of $113,700.00.
  • On Thursday, February 22nd, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $15.05, for a total transaction of $90,300.00.

HilleVax Trading Down 2.7 %

Shares of HLVX opened at $14.14 on Thursday. The firm has a fifty day moving average of $14.57 and a 200-day moving average of $14.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 10.92 and a quick ratio of 10.92. HilleVax, Inc. has a 1 year low of $9.94 and a 1 year high of $20.22.

HilleVax (NASDAQ:HLVXGet Free Report) last posted its earnings results on Wednesday, March 20th. The company reported ($0.78) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.80) by $0.02. Equities analysts forecast that HilleVax, Inc. will post -3.14 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HLVX shares. HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of HilleVax in a research report on Friday, May 10th. JPMorgan Chase & Co. lifted their target price on HilleVax from $21.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, May 15th.

View Our Latest Stock Analysis on HilleVax

Institutional Trading of HilleVax

Large investors have recently added to or reduced their stakes in the business. Deerfield Management Company L.P. Series C raised its stake in shares of HilleVax by 20.3% during the third quarter. Deerfield Management Company L.P. Series C now owns 4,004,231 shares of the company’s stock valued at $53,857,000 after purchasing an additional 675,000 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of HilleVax by 4.1% during the fourth quarter. Franklin Resources Inc. now owns 1,846,396 shares of the company’s stock valued at $29,635,000 after acquiring an additional 71,938 shares during the period. Braidwell LP raised its holdings in HilleVax by 16.0% during the third quarter. Braidwell LP now owns 1,449,246 shares of the company’s stock worth $19,492,000 after purchasing an additional 200,000 shares in the last quarter. Catalys Pacific LLC bought a new position in HilleVax during the 4th quarter valued at $21,009,000. Finally, StepStone Group LP raised its stake in shares of HilleVax by 22.2% in the 3rd quarter. StepStone Group LP now owns 826,567 shares of the company’s stock worth $11,117,000 after buying an additional 149,998 shares in the last quarter. 86.42% of the stock is currently owned by institutional investors and hedge funds.

HilleVax Company Profile

(Get Free Report)

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.

Read More

Insider Buying and Selling by Quarter for HilleVax (NASDAQ:HLVX)

Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.